Legal Medicine
Volume 12, Issue 2 , Page 112 , March 2010

Is “Toxopsy” the next step after virtopsy?

Received 3 October 2009 ,Revised 20 November 2009 ,Accepted 2 December 2009.

References 

  1. Maeda H, Zhu B-L, Ishikawa T, Quan L, Michiue T. Significance of post-mortem biochemistry in determining the cause of death. Leg Med. 2009;11:S1–4
  2. Henssge C, Madea B. Estimation of the time since death. Forensic Sci Int. 2007;165:182–184
  3. Madea B, Musshoff F. Postmortem biochemistry. Forensic Sci Int. 2007;165:165–171
  4. Uemura K, Shintani-Ishida K, Saka K, Nakajima M, Ikegaya H, Kikuchi Y, et al. Biochemical blood markers and sampling sites in forensic autopsy. J Forensic Leg Med. 2008;15:312–317
  5. Madea B. Is there recent progress in the estimation of the postmortem interval by means of thanatochemistry?. Forensic Sci Int. 2005;151:139–149
  6. Yoshida C, Ishikawa T, Michiue T, Quan L, Maeda H. Postmortem biochemistry and immunohistochemistry of chromogranin A as a stress marker with special regard to fatal hypothermia and hyperthermia. Int J Legal Med. 2009;[Epub ahead of print]
  7. Cina SJ, Li DJ, Chan DW, Boitnott JK, Hruban RH, Smialek JE. Serum concentrations of cardiac troponin I in sudden death: a pilot study. Am J Forensic Med Pathol. 1998;19:324–328
  8. Dirnhofer R, Jackowski C, Vock P, Potter K, Thali MJ. VIRTOPSY: minimally invasive, imaging-guided virtual autopsy. Radiographics. 2006;26:1305–1333

PII: S1344-6223(09)00367-8

doi: 10.1016/j.legalmed.2009.12.001

Legal Medicine
Volume 12, Issue 2 , Page 112 , March 2010

Article Tools